Skip to content

Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases

Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01825538
Enrollment
93
Registered
2013-04-05
Start date
2013-02-28
Completion date
2014-06-30
Last updated
2014-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis

Keywords

Chronic obstructive pulmonary disease, Pulmonary fibrosis, Advanced care planning

Brief summary

To understand current practices of pulmonary physicians in relation to Advanced Care Planning (ACP) in order to develop future disease-specific tools that will improve patient-physician communication about ACP.

Detailed description

The study will be a retrospective, observational study and analysis of charts of patients with Chronic Obstructive Pulmonary Disease (COPD) or pulmonary fibrosis treated as outpatients at the Ohio State University Wexner Medical Center Lung Center. Using pre-existing data, we will determine if advanced care planning has been discussed with these patients and record this information. For all patients, we will gather data about specific demographic and clinical characteristics that may have contributed to the presence or absence of these discussions. The study is descriptive in nature and is not powered to detect a difference between the two groups. Instead, we aim to describe the characteristics most frequently associated with advanced care planning discussion in these two particular groups. Potential subjects will be identified with assistance from the Information Warehouse. After identification, data will be abstracted from pre-existing data in the electronic medical record and collected in a coded fashion for each subject. Each subject will be assigned an anonymous subject identification number and all links to identifying information will be destroyed prior to analysis. All study data will be stored on a secure password protected data base to which only study personnel will have access.

Interventions

None listed

Sponsors

Jennifer McCallister MD
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 88 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who are between 18 and 88 years of age who have been diagnosed with a physician diagnosis of COPD based on at least one of the following: * clinical history - a documented history of COPD, emphysema, or chronic bronchitis. * pulmonary function results - defined as an forced expiratory volume in one second to forced vital capacity ratio (FEV1/FVC) less than 0.7 2. Patients who are between 18 and 88 years of age and have been diagnosed with pulmonary fibrosis based on the following: * Subpleural, basal predominance of parenchymal abnormality on high resolution computed tomography (HRCT) * Reticular abnormality on HRCT * Honeycombing without traction bronchiectasis on HRCT * Absence of features that are inconsistent with usual interstitial pneumonia (UIP) pattern OR * UIP based on surgical lung biopsy

Exclusion criteria

* Age \< 18 years or \> 88 years * Prisoners * Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Record the presence or absence of Advanced Care Planning (ACP) discussions with patients with advanced lung diseaseLast two yearsThis is a descriptive study which will retrospectively review whether Advanced Care Planning discussions have been documented in the medical records of patients with chronic obstructive pulmonary disease or pulmonary fibrosis. Using pre-existing data, we will determine if Advanced Care Planning has been discussed with these patients and record this information.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026